Filing Details

Accession Number:
0001104659-20-124504
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-12 17:31:26
Reporting Period:
2020-11-10
Accepted Time:
2020-11-12 17:31:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1175151 Cytosorbents Corp CTSO Surgical & Medical Instruments & Apparatus (3841) 980373793
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1368152 Al Kraus C/O Cytosorbents Corporation
7 Deer Park Drive, Suite K
Monmouth Junction NJ 08852
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-10 8,000 $3.45 133,046 No 4 M Direct
Common Stock Disposition 2020-11-10 8,000 $8.00 125,046 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2020-11-10 8,000 $0.00 8,000 $3.45
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2021-01-06 No 4 M Direct
Footnotes
  1. These shares were sold in multiple transactions and multiple lots for the same price for this sale have been combined.
  2. Includes: (i) the following RSUs that will be settled into common stock upon vesting upon a "Change In Control" of CytoSorbents Corporation (the "Company") as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 55,000 RSUs granted on April 8, 2015, (b) 5,000 RSUs granted on June 7, 2016, (c) 6,000 RSUs granted on February 24, 2017 and (d) 3,300 RSUs granted on March 15, 2018; and (ii) 55,746 shares of common stock owned by the reporting person.
  3. These options were originally granted to Mr. Kraus on January 6, 2011 as compensation for services rendered. The grant became fully vested on January 6, 2020.